Biomedical Bonding’s Bonevolent® technology is a result from a fruitful collaboration between surgeons and material scientists

Last week BMB participated in Flipday VetTech, organized by SLU Holding and Green Innovation Park. An excellent event where we presented...

Meet us in person August 24th – 26th at the Scandinavian Society for Surgery of the Hand (SSSH) conference 2022 taking place in Malmö,...

Press release: Biomedical Bonding's unique primer formulation to enable strong adhesion between difficult substrates such as wet bone and...

Press release: Biomedical Bonding AB has, together with consortium partners KTH Royal Institute of Technology, RISE Research Institutes...

Press release: Biomedical Bonding AB, a Swedish MedTech company with focus on patient-personalized implants for the treatment of bone...

News release: Biomedical Bonding expands its Bonevolent™ composite bone fracture fixators to include animal care. The Company has...

News: AdhFix is highlighted by the Swedish Medtech Magazine as a new method for treating complex bone fractures. The article is a result...

Press release: Biomedical Bondings AdhFix product can personalize patient care of complex fractures by applying a composite instead of...

With the growing need for novel treatments in the orthopedic and dental market, Biomedical Bonding AB (BMB) is continuing to pursue an...

BMB has secured a strong position in novel resin-based implants via granted patents in Europe and pending approval of patents in other...

BMB secures new R&D facilities at Greenhouse labs, GHL. The new address is located at KTH Royal Institute of Technology main campus in...

Preclinical in vivo study. DendroPrime avoided tissue-adhesions and overgrowth to improve joint mobility and alleviate plate removal....

We are happy to be part of the future of bone healing! Biomedical Bonding AB (BMB) has been granted financing from the EU research and ...

The Swedish government support a R&D project with focus on BMB’s Bonevolent® technology. The funded project comprises 4 partners: KTH ...

BMB is happy to announce the completion of its one year safety and performance study of Bonevolent™- AdhFix on rodant. The study was ...

Biomedical Bonding AB has in December 2019 submitted a new patent application that relates to adhesive technology for hard tissue...

Our adhesive fixators, as future standard-of-care fracture solutions, were translated to clinical use on human cadaver substrates. The...

Biomedical Bonding AB is happy to announce that it has secured the trademark BONEVOLENT® for the European market. BONEVOLENT™ covers: 1. ...

Our fracture fixator technology AdhFix was awarded Seal of Excellence from the European Commission for its high level of excellence and...